Literature DB >> 35403139

Correlation Between the Transient Elevation of Peripheral Eosinophil Count During Radiotherapy and Acute Diarrhea.

Takako Kobayashi1, Fumiaki Isohashi1, Daisuke Eino1, Kazunori Tanaka1, Kenjiro Sawada2, Yutaka Ueda2, Eiji Kobayashi2, Takuji Tomimatsu2, Tadashi Kimura2, Kazuhiko Ogawa1.   

Abstract

Background/Aim: This study aimed to evaluate the association between the change in peripheral eosinophil count during postoperative pelvic radiotherapy and gastrointestinal (GI) toxicities in patients with cervical cancer. Patients and
Methods: The medical records of 163 patients with cervical cancer who underwent postoperative concurrent chemoradiotherapy between 2000 and 2016 were analyzed.
Results: Among the peripheral blood cell counts, transient elevation of the eosinophil count was observed during radiotherapy. Of the 163 patients, 117 developed grade ≥2 diarrhea during radiotherapy, and 25 patients developed grade ≥2 late GI toxicities. In multivariate analysis, the maximum eosinophil count and age emerged as independent predictors of grade ≥2 acute diarrhea during radiotherapy, while bowel bag V 40 Gy and age were predictive of grade ≥2 late GI toxicities.
Conclusion: Early detection of transient elevation of eosinophil may facilitate early treatment of acute diarrhea during radiotherapy. Copyright 2021, International Institute of Anticancer Research.

Entities:  

Keywords:  Acute diarrhea; cervical neoplasm; eosinophil; late; postoperative; toxicity

Year:  2021        PMID: 35403139      PMCID: PMC8988959          DOI: 10.21873/cdp.10044

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  19 in total

1.  Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiation therapy for early-stage cervical cancer.

Authors:  Fumiaki Isohashi; Yasuo Yoshioka; Seiji Mabuchi; Koji Konishi; Masahiko Koizumi; Yutaka Takahashi; Toshiyuki Ogata; Shintaroh Maruoka; Tadashi Kimura; Kazuhiko Ogawa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-23       Impact factor: 7.038

2.  Clinical outcomes and toxicity of postoperative intensity-modulated versus three-dimensional conformal radiation therapy in patients with cervical cancer.

Authors:  Mei-Ling Lan; Xian Yu; He Xiao; Peng Zhou; Nan Hu; Jian Li; Ge Wang
Journal:  Asia Pac J Clin Oncol       Date:  2016-02-28       Impact factor: 2.601

3.  Eosinophil depletion suppresses radiation-induced small intestinal fibrosis.

Authors:  Naoki Takemura; Yosuke Kurashima; Yuki Mori; Kazuki Okada; Takayuki Ogino; Hideki Osawa; Hirosih Matsuno; Lamichhane Aayam; Satoshi Kaneto; Eun Jeong Park; Shintaro Sato; Kouta Matsunaga; Yusuke Tamura; Yasuo Ouchi; Yutaro Kumagai; Daichi Kobayashi; Yutaka Suzuki; Yoshichika Yoshioka; Junichi Nishimura; Masaki Mori; Ken J Ishii; Mark E Rothenberg; Hiroshi Kiyono; Shizuo Akira; Satoshi Uematsu
Journal:  Sci Transl Med       Date:  2018-02-21       Impact factor: 17.956

4.  Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients.

Authors:  K Holub; A Biete
Journal:  Clin Transl Oncol       Date:  2018-11-23       Impact factor: 3.405

Review 5.  Role of eosinophils in inflammatory bowel and gastrointestinal diseases.

Authors:  Samantha A Woodruff; Joanne C Masterson; Sophie Fillon; Zachary D Robinson; Glenn T Furuta
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-06       Impact factor: 2.839

6.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

Authors:  W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

7.  Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy.

Authors:  Miao-Fen Chen; Chih-Jen Tseng; Ching-Cheng Tseng; Yuen-Chun Kuo; Chun-Yen Yu; Wen-Cheng Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-01       Impact factor: 7.038

8.  Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?

Authors:  L Wedlake; C McGough; C Hackett; K Thomas; P Blake; K Harrington; D Tait; V Khoo; D Dearnaley; H J N Andreyev
Journal:  Aliment Pharmacol Ther       Date:  2008-02-27       Impact factor: 8.171

Review 9.  Histopathology of Non-IBD Colitis. A practical approach from the Italian Group for the study of the gastrointestinal tract (GIPAD).

Authors:  Vincenzo Villanacci; Luca Reggiani-Bonetti; Giuseppe Leoncini; Paola Parente; Moris Cadei; Luca Albarello; Giulio Mandelli; Alessandro Caputo
Journal:  Pathologica       Date:  2021-02

10.  A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy.

Authors:  Rashmi Jadon; Emma Higgins; Louise Hanna; Mererid Evans; Bernadette Coles; John Staffurth
Journal:  Radiat Oncol       Date:  2019-04-03       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.